✦ LIBER ✦

Renal Cell Carcinoma || C-MET as a Novel Target for the Treatment of Renal Cell Carcinoma

✍ Scribed by Figlin, Robert A.; Rathmell, W. Kimryn; Rini, Brian I.

Book ID: 120357895
Publisher: Springer US
Year: 2012
Weight: 398 KB
Category: Article
ISBN: 1461424003
DOI: 10.1007/978-1-4614-2400-0_10

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal Cell Carcinoma || Mammalian Target

Renal Cell Carcinoma || Mammalian Target of Rapamycin in Renal Cell Carcinoma

✍ Campbell, Steven C.; Rini, Brian I. 📂 Article 📅 2012 🏛 Humana Press ⚖ 486 KB

Inactivation of VHL gene induces constit

Inactivation of VHL gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma: MET protein as a novel target for renal carcinoma therapy

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Cabozantinib as a Novel Therapy for Rena

Cabozantinib as a Novel Therapy for Renal Cell Carcinoma

✍ Ulka Vaishampayan 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 152 KB

Targeted agents for the treatment of adv

Targeted agents for the treatment of advanced renal cell carcinoma

✍ Walter M. Stadler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

Novel therapeutics for metastatic renal

Novel therapeutics for metastatic renal cell carcinoma

✍ Thomas E. Hutson; Robert A. Figlin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract The treatment of metastatic renal cell carcinoma (RCC) has changed dramatically during the past few years. Sunitinib malate, sorafenib tosylate, bevacizumab with interferon α, temsirolimus, and everolimus have improved clinical outcomes in randomized phase 3 trials by inhibiting the vas

HEPATITIS C AS A RISK FACTOR FOR RENAL C

HEPATITIS C AS A RISK FACTOR FOR RENAL CELL CARCINOMA

✍ Rogers, Craig G; Patel, Manish N; Lamerato, Lois; Gordon, Stuart 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 54 KB